Moneycontrol PRO
LAMF
LAMF

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy Sun Pharmaceutical Industries, Manappuram Finance, Mahindra & Mahindra: Rahul Shah

  • Buy Federal Bank 115 Call, RBL Bank 550 Call, Sun Pharma 660 Call: VK Sharma

  • Hold Glenmark Pharma, says Rajat Bose

  • Buy Hindustan Unilever, Mindtree, Sun Pharma; sell Jaiprakash Associates: Sudarshan Sukhani

  • Here are a few stock ideas from SP Tulsian

  • Buy Mahindra & Mahindra, Sun Pharmaceutical Industries, Piramal Enterprises: Rahul Shah

  • Buy Indo Count Industries, Dr Reddy's Laboratories, Motherson Sumi: Chandan Taparia

  • Hold Sun Pharma, says Rajat Bose

  • Prefer Natco Pharma, says Gaurang Shah

  • Goldman Sachs retains Buy on Sun Pharma after USFDA accepts NDA filing for OTX-101

  • Vedanta may test Rs 336, Sun Pharma Rs 600: Hemant Thukral

  • Buy, Sell, Hold: 4 stocks and 1 event are on analysts’ radar today

  • Look at Sun Pharma, says Prakash Diwan

  • Exit Wockhardt, prefer Sun Pharma: Shahina Mukadam

  • Buy Tech Mahindra, Apollo Hospitals Enterprises: Ashwani Gujral

  • Buy SBI, Axis Bank, Sun Pharma: Yogesh Mehta

  • Top buy, sell ideas by Mitessh Thakkar, Sandeep Wagle & Ashwani Gujral for December 27

  • Buy Infibeam Incorporation, Sun Pharma: Mitessh Thakkar

  • Buy JSW Steel, Sun Pharma, Shriram Transport Finance: Rahul Shah

  • Top buy & sell ideas by Mitessh Thakkar & Prakash Gaba for December 21

  • Buy IndusInd Bank, JSW Steel, Sun Pharmaceutical Industries: Rahul Shah

  • Buy Granules India, Sun Pharmaceutical Industries: Prakash Gaba

  • Sun Pharma down 1% as CLSA maintains sell call

  • Buy, Sell, Hold: 10 stocks and 1 event are being tracked by analysts today

  • Top buy & sell ideas by Ashwani Gujral, Mitessh Thakkar & Prakash Gaba for December 7

Advisory Alert:

It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347